Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE TRIAL)
Abroad (travel likely)RecruitingPHASE2
Conditions
Kidney Transplant
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Cedars Sinai Medical Center, Los Angeles, California, United States
Northwestern Memorial Hospital, Chicago, Illinois, United States
Kansas University Medical Center, Kansas City, Kansas, United States
Montefiore Medical Center, The Bronx, New York, United States
Study leads
Peter S Heeger, MD
Study Chair
Cedars-Sinai Medical Center
Sindhu Chandran, MBBS, MD
Study Chair
Cedars-Sinai Medical Center
Stanley Jordan, MD
Study Chair
Cedars-Sinai Medical Center